Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling

BACKGROUND: Non-small-cell lung cancer (NSCLC) is the major leading cause of cancer-related death around the world. The resistance to chemotherapy limits the effects of clinical treatment. The aim of this study was to identify novel mechanisms involved in NSCLC chemoresistance. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Han, Tianci, Tong, Wei, Zhao, Jian, Qiu, Xueshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163007/
https://www.ncbi.nlm.nih.gov/pubmed/30288060
http://dx.doi.org/10.2147/OTT.S175606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163007/
https://www.ncbi.nlm.nih.gov/pubmed/30288060
http://dx.doi.org/10.2147/OTT.S175606

Ejemplares similares